» Articles » PMID: 32802097

Kisspeptin-13 Improves Spatial Memory Consolidation and Retrieval Against Amyloid-β Pathology

Overview
Publisher Brieflands
Specialty Pharmacology
Date 2020 Aug 18
PMID 32802097
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

It has been shown that brain glucose metabolism impairment, obesity, and diabetes could lead to cognitive decline and Alzheimer's disease (AD) pathogenesis. Kisspeptin (KP) a G-protein coupled receptor neuropeptide, has been suggested as a link between energy balance and reproduction. Some studies have shown that the attenuation of KP signaling decreases metabolism and energy expenditure. KP mRNAs and receptors are detected in the hippocampus and cause the promotion of excitatory synaptic responses through modulation of postsynaptic signaling. The purpose of this study was to investigate the effect of KP on spatial learning and memory and its possible neuroprotective effect on Amyloid-Beta induced cognitive impairment using the Morris Water Maze (MWM) task in rats. The reference and reversal spatial learning and memory have been measured in this study. Rats were injected bilaterally by Aβ1-42 (2 μg/μL) or saline as a vehicle into the hippocampal CA1 area. One week later, KP-13 (1.5 or 2 µg/µL) was injected i.c.v before or after each training session for 3 days and memory was tested 24 h later. The results showed KP-13 by itself could significantly enhance spatial memory consolidation and retrieval, and Aβ induced reversal and reference memory impairment was significantly ameliorated by KP-13. In Conclusion, it seems that KP-13 as a neuropeptide has to enhance spatial memory properties and could be a possible neuroprotective peptide on amyloid-beta induced pathology.

Citing Articles

Kisspeptin is elevated in the brain after intracerebral haemorrhagic stroke.

Maheshwari S, Um I, Donachie S, Asghar N, McDade K, Millar T Sci Rep. 2024; 14(1):32046.

PMID: 39738446 PMC: 11685885. DOI: 10.1038/s41598-024-83514-0.


Brain RFamide Neuropeptides in Stress-Related Psychopathologies.

Kovacs A, Szabo E, Laszlo K, Kertes E, Zagoracz O, Mintal K Cells. 2024; 13(13.

PMID: 38994950 PMC: 11240450. DOI: 10.3390/cells13131097.


The effect of ghrelin on antioxidant status in the rat's model of Alzheimer's disease induced by amyloid-beta.

Sarlaki F, Shahsavari Z, Goshadrou F, Naseri F, Keimasi M, Sirati-Sabet M Biomedicine (Taipei). 2023; 12(4):44-54.

PMID: 36816173 PMC: 9910231. DOI: 10.37796/2211-8039.1341.


Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease.

Miziak B, Blaszczyk B, Czuczwar S Pharmaceuticals (Basel). 2021; 14(5).

PMID: 34068096 PMC: 8152728. DOI: 10.3390/ph14050458.


Kisspeptin-54 attenuates oxidative stress and neuronal apoptosis in early brain injury after subarachnoid hemorrhage in rats via GPR54/ARRB2/AKT/GSK3β signaling pathway.

Huang Y, Guo Y, Huang L, Fang Y, Li D, Liu R Free Radic Biol Med. 2021; 171:99-111.

PMID: 33989759 PMC: 8388553. DOI: 10.1016/j.freeradbiomed.2021.05.012.


References
1.
Gholamipour-Badie H, Naderi N, Khodagholi F, Shaerzadeh F, Motamedi F . L-type calcium channel blockade alleviates molecular and reversal spatial learning and memory alterations induced by entorhinal amyloid pathology in rats. Behav Brain Res. 2012; 237:190-9. DOI: 10.1016/j.bbr.2012.09.045. View

2.
Walsh D, Klyubin I, Fadeeva J, Cullen W, Anwyl R, Wolfe M . Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002; 416(6880):535-9. DOI: 10.1038/416535a. View

3.
Cao B, Rosenblat J, Brietzke E, Park C, Lee Y, Musial N . Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis. Diabetes Obes Metab. 2018; 20(10):2467-2471. DOI: 10.1111/dom.13373. View

4.
Yamin G . NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J Neurosci Res. 2009; 87(8):1729-36. DOI: 10.1002/jnr.21998. View

5.
Dudek M, Ziarniak K, Sliwowska J . Kisspeptin and Metabolism: The Brain and Beyond. Front Endocrinol (Lausanne). 2018; 9:145. PMC: 5911457. DOI: 10.3389/fendo.2018.00145. View